Poster Presentations S81 hepatitis B patients. Long-term outcomes were better in those subjects with HBV DNA 10 5 copies/mL at Week 40.
PP-085 Large scale protein expressions for antigenomics studies of respiratory viruses G.L. Lu, L. Qin, S.J. Cui, J.W. Wang, T. Hung. Institute of Pathogen Biology, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing 100730, China Viruses are one of the major causes of acute respiratory tract illnesses (ARTIs) throughout the world. The classical common viruses causing ARTIs include influenza virus (IFV), parainfluenza viruses 1 4 (PIVs), enterovirus (EV), human rhinovirus (HRV), respiratory syncytial virus (RSV), adenovirus (AdV), and human coronavirus (HCoV) 229E and OC43. The improvement of molecular detection techniques has resulted in the recent identification of several new respiratory viruses, such as human metapneumovirus (hMPV), novel strains of coronaviruses (SARS-CoV, HCoV-NL63 and HCoV-HKU1), human bocavirus (HBoV), and novel polyomaviruses (WUPyV and KIPyV). The frequent emergency of severe diseases caused by respiratory viruses has made viral ARTIs a global health challenge with highpriority. The studies on the immunological features by antigenomics (including epitomics) analysis will provide basis for monitoring epidemic patterns, investigating the epidemiology and developing diagnosis and vaccines. We have developed a comprehensive platform to express and purify the major antigens encoded by IFVs, PIVs, RSV, hMPV, HCoV, AdV, etc. The purified products have been used to the study of respiratory virus antigenome and epitome, which will provide insight into the immunological properties of the viruses.
PP-086 Increase influenza virus yield by reverse
genetics system through a strong RNA Polymerase II promoter S.J. Cui, G.L. Lu, L. Qin, Z.D. Zhao, J.W. Wang, T. Hung.
Institute of Pathogen Biology, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing 100730, China
The vaccination program is a reliable strategy in controlling the prevalence of influenza epidemics. Due to the frequent variation, the recommended influenza virus strains for vaccine production have to be changed every year based on the surveillance data. Because the preparation of virus seed lots suitable for vaccine production is time-consuming, a simple approach to obtain the vaccine strains rapidly has been a priority topic in influenza vaccine research and development. The emergency of reverse genetic system of influenza virus allows the rapid production of influenza virus from cloned cDNAs and has been becoming a encouraging alternative approach for influenza virus seed generation. However, current reverse genetics techniques to rescue influenza viruses are based on bidirectional RNA Pol I Pol II transcription system, which can not meet to the need of human vaccine production because of low yield. Here we report improved the RNA polymerase II (pol II) promoter of mRNA synthesis have led to a significant higher-yielding vaccine strain production. These improvements pave the way for the reproducible generation of influenza virus vaccine strain and may be applicable to other reverse genetics systems.
